© Supplied by CNBCTV18 Astrazeneca will get promoting authorisation to use ant-diabetic issues drug for kidney illness Drug business AstraZeneca...
Kidney
The MarketWatch News Department was not involved in the creation of this content. Feb 03, 2021 (The Expresswire) -- Global...
The MarketWatch Information Section was not associated in the generation of this information. Jan 25, 2021 (The Expresswire) -- “International...